Introduction
Renal cell carcinoma is the single most common malignancy of the kidney comprising of 3 % of all cancer diagnosed in human 1 . Detection of malignant renal masses and their differentiation from their benign counterparts is vital for management and treatment of patient. Treatment plan is changed accordingly. MDCT with its rapid scanning time and multiplanar reformatting ability has emerged as the single important tool for detection and characterization of renal mass. Material and study method The study was carried out on 60 patients within 2 years(october2017-october 2019)from the medical and urological wards of V.S.S Medical college, Burla with provisional diagnosis of renal mass or patients who were diagnosed to have renal mass on ultrasound and referred to CT for further characterization. Patients were evaluated with CANON 160n slice MDCT. Inclusion criteria All patients with clinically suspected renal mass Exclusion criteria Simple cyst was not included in the study Regarding age distribution of renal mass, in our study the maximum percentage of patients, 31 (51.7%) were in the age range of 60-69 years.26 out of 36 patients (72.2%) of renal cell carcinoma were in the age range of 60-69 years and was consistent with Gudbjarotsson et al 2 who have found that diagnosis of renal cell carcinoma peaks in 6 th decade. 8 out of 8 patients with Wilms tumor were below 10 years of age which was correlated with Lonergan et al 3 who have described that peak incident of wilm tumor is at 3-4 year. Regarding gender distribution of renal mass,in our study male:female=1.7:1. There is male dominance (69.5%) in case of renal cell carcinoma which was well correlated with Verhoest G et al 4 .
Results
In our study, out of 60 cases, 50 cases diagnosed to be malignant (83%) and 10 cases diagnosed to be benign (17%). Renal cell carcinoma (n=36) accounted for 60% of renal mass and 72% of malignant renal mass. Transitional cell tumor (n=3) accounted for 5% of renal mass, Wilms tumor (n=8) accounted for 13.3% of renal mass, metastasis (n=3) accounted for 5% of renal mass, complex cyst (n=4) accounted for 6.7 % of renal mass, renal abscess (n=3) accounted for 5% of renal mass, multilocular cystic nephroma (1) accounted for 1.7% of renal mass. This was consistent with Smith et al 5 . Regarding image characteristics of renal mass, in our study calcification has been seen 13 out of 36 case of renal cell carcinoma(36.1%). Malignant renal masses showed more amount of necrosis when compared to the bening renal masses (55.6% in RCC and 100% in Wilms tumor). Renal vein invasion has been seen 22.2% cases of RCC and 37.5% cases of Wilms tumor. 3 out of 36 (8.3%) cases of RCC showed inferior renal vein thrombosis. The most common site of metastasis from RCC was to lymphnode (33.3%) and from Wilms tumor was to lymphnode (50%). This study was well correlated with Zagoria et al 6 . In our study, from table-6 renal cell carcinoma displayed soft tissue attenuation on precontrast study and HU of 65.3% and 85.3% n CMP and NP respectively which was correlated with Garant et al 7 and Jinaki et al 8 where they have showed RCC being very vascular tumor showing significant enhancement (>20 HU) in CMP and NP. In our study, we compared the CMP and NP to the UE phase and increase in 20 HU was taken as malignant. This was well correlated with Kopka et al 9 study who have evaluated the combination of UE, CMP and NP in detection of renal mass.
Conclusion
Evaluation of renal mass by MDCT can provide information regarding extent of the lesion, lesion enhancement pattern, surrounding structure invasion. Differentiation of renal mass into benign and malignant lesion is possible by the enhancement pattern used in CT scan so that clinician can take proper decision on patient's treatment and management. So MDCT is certainly a sensitive tool for detection and characterization of renal mass.
